NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds
Status:
Completed
Trial end date:
2018-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of NM-IL-12 relative to
standard of care (SOC; control) in subjects with open surgical wounds.
Phase:
Phase 2
Details
Lead Sponsor:
Neumedicines Inc.
Collaborator:
U.S. Army Medical Research and Development Command